At-Home Diagnostic Systems : genhome

GenHome, the in vitro diagnostic platform based on molecular diagnosis for self-examination, is a CES 2024 Innovation Awards Honoree in the Digital Health category that introduces the future of at-home diagnostics. This hybrid diagnostic system combines isothermal amplification and LFA (lateral flow assay) to ensure accuracy and 100 times the precision of conventional rapid tests.

This everyday wellness device is poised to usher in a new era of affordable healthcare by having users collect oral or nasal swabs, and place them within a secure unit for testing. After some time has passed, the device reveals the results, indicating whether a user has tested positive or negative (or if the results were invalid) for COVID-19, influenza and RSV, all at once.